Drug Markets/Ziprasidone Mesylate

Ziprasidone Mesylate

5 NDCs across 3 manufacturers|5 Generic,0 Brand

Ziprasidone Mesylate is used to treat schizophrenia and tourette syndrome, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Jun 21, 2002, and the first generic was approved Dec 26, 2019. In 2024, Medicare Part D spent $514K on Ziprasidone Mesylate across 2,863 claims for 1,309 beneficiaries.

Ziprasidone Mesylate is available as 5 NDCs from 3 manufacturers (5 generic, 0 brand), with NADAC prices from $21.81 to $21.81 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

5

5G / 0B

Manufacturers

3

competing in market

Price Spread

$21.81 – $21.81

per EA

7d Activity

5 flat

avg +0.0% WoW · of 5 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

5 NDCs total, 5 shown

Frequently Asked Questions

What is Ziprasidone Mesylate used to treat?

Ziprasidone Mesylate is used to treat schizophrenia and tourette syndrome, per the National Library of Medicine's MED-RT classification.

When did Ziprasidone Mesylate become available as a generic?

FDA approved the first generic Ziprasidone Mesylate (ANDA) on Dec 26, 2019.

How much does Medicare spend on Ziprasidone Mesylate?

In 2024, Medicare Part D spent $514K on Ziprasidone Mesylate across 2,863 claims for 1,309 beneficiaries.

How many Ziprasidone Mesylate products are on the market?

The Ziprasidone Mesylate drug market contains 5 NDCs from 3 manufacturers — 5 generic and 0 brand products.

What is the price range for Ziprasidone Mesylate?

NADAC reference prices for Ziprasidone Mesylate range from $21.8074 to $21.8074 per EA.

Which manufacturers make Ziprasidone Mesylate?

3 manufacturers list Ziprasidone Mesylate in NADAC. Ranked by number of NDCs, the largest are Dr. Reddy's Laboratories Inc. (2), Fosun Pharma USA Inc. (2), Novadoz Pharmaceuticals LLC (1).